Initiating insulin with, or switching insulin therapy to, BIAsp 30 in routine care resulted in improved glycaemic control, reduced major hypoglycaemia and greater treatment satisfaction.

• 与起始胰岛素或转为胰岛素治疗相比，预混双相门冬胰岛素30在常规护理的结果中改善了血糖控制，减少了低血糖和提高了治疗满意度。